JUSTIN ZACHARIAH to Dyslipidemias
This is a "connection" page, showing publications JUSTIN ZACHARIAH has written about Dyslipidemias.
Connection Strength
3.061
-
Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease. Curr Atheroscler Rep. 2023 07; 25(7):417-426.
Score: 0.740
-
Lipid temporal trends in normal-weight youth. Am Heart J. 2021 01; 231:68-72.
Score: 0.616
-
Adolescent Dyslipidemia and Standardized Lifestyle?Modification: Benchmarking Real-World Practice. J Am Coll Cardiol. 2016 11 08; 68(19):2122-2123.
Score: 0.469
-
Pediatric lipid management: an earlier approach. Endocrinol Metab Clin North Am. 2014 Dec; 43(4):981-92.
Score: 0.410
-
The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemia. BMC Pediatr. 2019 07 02; 19(1):217.
Score: 0.141
-
Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia. J Pediatr Gastroenterol Nutr. 2019 02; 68(2):175-181.
Score: 0.137
-
Statin Use and the Risk of Type 2 Diabetes Mellitus in Children and Adolescents. Acad Pediatr. 2017 07; 17(5):515-522.
Score: 0.119
-
Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia. J Pediatr. 2016 Nov; 178:149-155.e9.
Score: 0.116
-
Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 years. J Clin Lipidol. 2016 Jul-Aug; 10(4):824-832.e2.
Score: 0.112
-
Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years. J Pediatr. 2015 Jul; 167(1):113-9.e1.
Score: 0.105
-
Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2011 May; 31(5):1208-14.
Score: 0.079
-
Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community. Circ Cardiovasc Genet. 2010 Jun; 3(3):300-6.
Score: 0.019